Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults

Vaccine

Volumn 25, Issue 17, 2007, Pages 3464-3474

  McNeil, Shelly A ^a,b   Noya, Francisco ^c   Dionne, Marc ^d   Predy, Gerald ^e   Meekison, William ^f   Ojah, Cecil ^b   Ferro, Santiago ^g   Mills, Elaine L ^g   Langley, Joanne M ^a,b   Halperin, Scott A ^a,b  

^a QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

^b SAINT JOHN REGIONAL HOSPITAL   (Canada)

^c MONTREAL CHILDREN S HOSPITAL   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e Northern Alberta Clinical Trials and Research Centre   (Canada)

^f Westcoast Clinical Research   (Canada)

^g Sanofi Pasteur   (Canada)

Author keywords

Bordetella pertussis; Concomitant vaccination; Influenza vaccine; Tdap

Indexed keywords

ANTIGEN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; INFLUENZA VACCINE;

ADULT; ADVERSE OUTCOME; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BODY ACHE; BORDETELLA PERTUSSIS; CHILL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG FORMULATION; DRUG SAFETY; ENERGY; FATIGUE; FEMALE; FEVER; HEADACHE; HEART INFARCTION; HUMAN; IMMUNOGENICITY; INJECTION SITE; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; JOINT SWELLING; LYMPH NODE SWELLING; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE WEAKNESS; NAUSEA; PAIN ASSESSMENT; PERTUSSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; VIRUS STRAIN; VOMITING;

ADULT; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; DIPHTHERIA TOXOID; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; TETANUS TOXOID; VACCINES, COMBINED; VACCINES, INACTIVATED;

EID: 34047266166     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.12.047     Document Type: Article

References (60)

1. Cherry J.D., and Heininger U. Pertussis and other Bordetella infections. In: Feigin R.D., Cherry J.D., Demmler G.J., and Kaplan S. (Eds). Textbook of pediatric infectious diseases. 5th ed. (2004), W.B. Saunders, Philadelphia 1588-1608
2. Edwards K.M., and Decker M.D. Pertussis vaccine. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 4th ed. (2004), W.B. Saunders, Philadelphia 471-578
3. Skowronski D.M., De Serres G., MacDonald D., Wu W., Shaw C., Macnabb J., et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis 185 (2002) 1448-1453
4. De Serres G., Shadmani R., Duval B., Boulianne N., Dery P., Douville Fradet M., et al. Morbidity of pertussis in adolescents and adults. J Infect Dis 182 (2000) 174-179
5. Guris D., Strebel P.M., Bardenheier B., Brennan M., Tachdjian R., Finch E., et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis 28 (1999) 1230-1237
6. Biellik R.J., Patriarca P.A., Mullen J.R., Rovira E.Z., Brink E.W., and Mitchell P. Risk factors for community- and household-acquired pertussis during a large-scale outbreak in central Wisconsin. J Infect Dis 157 (1988) 1134-1141
7. Robertson P.W., Goldberg H., Jarvie B.H., Smith D.D., and Whybin L.R. Bordetella pertussis infection: a cause of persistant cough in adults. Med J Aust 146 (1987) 522-525
8. Wirsing von Konig C.H., Postels-Multani S., Bock H.L., and Schmitt H.J. Pertussis in adults: frequency of transmission after household exposure. Lancet 346 (1995) 1326-1329
9. Wright S.W., Edwards K.M., Decker M.D., and Zeldin M.H. Pertussis infection in adults with persistent cough. JAMA 273 (1995) 1044-1046
10. Postels-Multani S., Schmitt H.J., Wirsing von Konig C.H., Bock H.L., and Bogaerts H. Symptoms and complications of pertussis in adults. Infection 23 (1995) 139-142
11. Schmitt-Grobe S., Cherry J.D., Heininger U., Uberall M.A., Pineda E., and Stehr K. Pertussis in German adults. Clin Infect Dis 21 (1995) 860-866
12. Aoyama T., Harashima M., Nishimura K., and Saito Y. Outbreak of pertussis in highly immunized adolescents and its secondary spread to their families. Acta Paediatr Jpn 37 (1995) 321-324
13. Mink C.M., Sirota N.M., and Nugent S. Outbreak of pertussis in a fully immunized adolescent and adult population. Arch Pediatr Adolesc Med 148 (1994) 153-157
14. Rosenthal S., Strebel P., Cassiday P., Sanden G., Brusuelas K., and Wharton M. Pertussis infection among adults during the 1993 outbreak in Chicago. J Infect Dis 171 (1995) 1650-1652
15. Deville J.G., Cherry J.D., Chirstenson P.D., Pineda E., Leach C.T., Kuhls T.L., et al. Frequency of unrecognized Bordetella pertussis infections in adults. Clin Infect Dis 21 (1995) 639-642
16. Nennig M.E., Shinefield H.R., Edwards K.M., Black S.B., and Fireman B.H. Prevalence and incidence of adult pertussis in an urban population. JAMA 275 (1996) 1672-1674
17. Marchant C.D., Loughlin A.M., Lett S.M., Todd C.W., Wetterlow L.H., Bicchieri R., et al. Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness. J Infect Dis 169 (1994) 1297-1305
18. Cherry J.D. Epidemiological, clinical, and laboratory aspects of pertussis in adults. Clin Infect Dis 28 (1999) S112-S117
19. Halperin S.A. Pertussis immunization for adolescents: what are we waiting for?. Can J Infect Dis 12 (2001) 74-76
20. Senzilet L.D., Halperin S.A., Spika J.S., Alagaratnam M., Morris A., Smith B., et al. Pertussis is a frequent cause of prolonged cough illness in adolescents and adults. Clin Infect Dis 32 (2001) 1691-1697
21. Strebel P., Nordin J., Edwards K., Hunt J., Besser J., Burns S., et al. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996. J Infect Dis 183 (2001) 1353-1359
22. Jansen D.L., Gray G.C., Putnam S.D., Lynn F., and Meade B.D. Evaluation of pertussis in US Marine Corps trainees. Clin Infect Dis 25 (1997) 1099-1107
23. Jackson L.A., Cherry J.D., San-Pin W., and Grayston J.T. Frequency of serological evidence of bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses. Clin Infect Dis 31 (2000) 3-6
24. Halperin S.A., Wang E.L., Law B., Mills E., Morris R., Dery P., et al. Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program-Active (IMPACT). Clin Infect Dis 28 (1999) 1238-1243
25. Ward J.I., Cherry J.D., Chang S.J., Partridge S., Lee H., Treanor J., et al. Efficacy of acellular pertussis vaccine among adolescents and adults. N Engl J Med 353 (2005) 1555-1563
26. Hodder S.L., Cherry J.D., Mortimer E.A., Ford A.B., Gornbein J., and Papp K. Antibody responses to Bordetella pertussis antigens and clinical correlations in elderly community residents. Clin Infect Dis 31 (2000) 7-14
27. Mink C.A., Cherry J.D., Christenson P., Lewis K., Pineda E., Shlian D., et al. A search for Bordetella pertussis infections in university students. Clin Infect Dis 14 (1992) 464-471
28. Biellik R.J., Patriarca P.A., Mullen J.R., Rovira E.Z., Brink E.W., Mitchell P., et al. Risk factors for community- and household-acquired pertussis during a large-scale outbreak in central Wisconsin. J Infect Dis 157 (1988) 1134-1141
29. Mortimer Jr. E.A. Pertussis and its prevention: a family affair. J Infect Dis 161 (1990) 473-479
30. Nelson J.D. The changing epidemiology of pertussis in young infants: the role of adults as reservoirs of infection. Am J Dis Child 132 (1978) 371-373
31. Gan V.N., and Murphy T.V. Pertussis in hospitalized children. Am J Dis Child 144 (1990) 1130-1134
32. Bisgard K.M., Pasqual F.B., Ehresmann K.R., Miller C.A., Cianfrini C., Jennings C.E., et al. Infant pertussis: who was the source?. Pediatr Infect Dis J 23 (2004) 985-989
33. Campins-Marti M., Cheng H.K., Forsyth K., Guiso N., Halperin S., Huang L.M., et al. International consensus group on pertussis immunization: rationale and strategies for consideration. Vaccine 20 (2001) 641-646
34. Keitel W.A., Muenz L.R., Decker M.D., Englund J.A., Mink C.M., Blumberg D.A., et al. A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose response comparisons of five vaccines and implications for booster immunizations. J Infect Dis 180 (1999) 397-403
35. Pichichero M.E., Rennels M.B., Edwards K.M., Blatter M.M., Marshall G.S., Bologa M., et al. Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults. JAMA 293 (2005) 3003-3011
36. Halperin S.A., Smith B., Russell M., Scheifele D., Mills E., Hasselback P., et al. An adult formulation of a 5-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine 18 (2000) 1312-1319
37. Pichichero M.E., Blatter M.M., Kennedy W.A., Hedrick J., Descamps D., and Friedland L.R. Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents. Pediatrics 117 4 (2006) 1084-1093
38. Van der Weilen M., Van Damme P., Joosens E., Francois G., Meurice F., and Ramalho A. A randomized controlled trial with a diphtheria-tetanus-acellular pertussis (dTap) vaccine in adults. Vaccine 18 (2000) 2075-2082
39. Southern J., Andrews N., Burrage M., and Miller E. Immunogenicity and reactogenicity of combined acellular pertussis/tetanus/low dose diphtheria vaccines given as a booster to UK teenagers. Vaccine 23 (2005) 3829-3835
40. National Advisory Committee on Immunization. Diphtheria toxoids. Canadian Immunization Guide. 5th ed. (1998), Minister of Public Works and Government, Ottawa, Canada p. 82-6
41. National Advisory Committee on Immunization. Tetanus toxoids. Canadian Immunization Guide. 5th ed. (1998), Minister of Public Works and Government, Ottawa, Canada p. 208-13
42. National Immunization Program, Centers for Diseases Control and Prevention. Advisory Committee on Immunization Practice (ACIP) Update on Adult Immunization Recommendations of the Immunization Practices Advisory Committee (ACIP). Accessed Dec. 22, 2005, at http://www.cdc.gov/mmwr/preview/mmwrhtml/00025228.htm.
43. National Advisory Committee on Immunization. Prevention of Pertussis in Adolescents and Adults. Can Comm Dis Rep 29 (2003) 1-12
44. Broder K.R., Cortese M.M., Iskander J.K., Kretsinger K., Slade B.A., Brown K.H., et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines: Recommendations of the Advisory Committee on Immunization Practices. MMWR 55 RR03 (2006) 1-34
45. The Brighton Collaboration: Swelling at or near the injection site as an adverse event following immunization-Case definition and guidelines for data collection, analysis, and presentation. Accessed at: http://www.brightoncollaboration.org.
46. Murphy B.R., Phalen M.A., Nelson D.L., Yarchoan R., Tierney E.L., Alling D.W., et al. Hemagglutinin-specific enzyme-linked immunosorbent assay for antibodies to influenza A and B viruses. J Clin Microbiol 13 3 (1981) 554-560
47. Wassilak S.G.F., Roper M.H., Murphy T.V., and Orenstein W.A. Tetanus toxoid. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 4th ed. (2004), WB Saunders Company, Philadelphia, PA 745-781
48. Galazka AM. Module 3: Tetanus. In: The immunological basis for immunization series. WHO/EPI/GEN/93.13, Geneva: World Health Organization; 1993.
49. Centers for Disease Control Prevention. General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP). MMWR 51 RR2 (2002) 1-35
50. Galazka AM. Module 2: Diphtheria. In: The immunological basis for immunization series. WHO/EPI/GEN/93.12, Geneva: World Health Organization; 1993.
51. Cox N.J., and Subbarao K. Influenza. Lancet 354 (1999) 1277-1282
52. Fukuda K., Levandowski R.A., Bridges C.B., and Cox N.J. Inactivated influenza vaccine. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 4th ed. (2004), WB Saunders Company, Philadelphia, PA 339-370
53. European Agency for the Evaluation of Medicinal Products (EMEA). Committee for Proprietary Medicinal Products (CPMP). Note for guidance on harmonization of requirements for influenza vaccines. CPMP/BWP/214/96; 12 March 1997.
54. Smith W.M., Bresee J.S., and Shay D.K. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR 55 RR10 (2006) 1-42
55. National Advisory Committee on Immunization. Statement on influenza vaccination for the 2006-2007 season. Can Comm Dis Report 32 (2006) 1-28
56. Keitel W. Cellular and acellular pertussis vaccines in adults. Clin Infect Dis 28 (1999) S118-S123
57. Englund J.A., Glezen W.P., and Barreto L. Controlled study of a new 5-component acellular pertussis vaccine in adults and young children. J Infect Dis 166 (1992) 1436-1441
58. Wilde J.A., McMillan J.A., and Serwint J. Effectiveness of influenza vaccine in health care professionals. A randomized trial. JAMA 281 (1999) 908-913
59. LaMontagne J.R., Noble G.R., Quinnan G.V., Curlin G.T., Blackwelder W.C., Smith J.I., et al. Summary of clinical trials of inactivated influenza vaccine-1978. Rev Infect Dis 5 (1983) 723-736
60. Gustafsson L., Hallander H., Olin P., Reizenstein E., and Storseater J. A controlled trial of a 2-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 334 6 (1996) 349-355